SyMRI to be studied as a technology to characterize brain tumors at cancer center in USA
SyntheticMR and The University of Texas MD Anderson Cancer Center have signed a research agreement to study SyMRI to characterize brain tumors. SyMRI provides quantitative information including tissue segmentation and T1, T2 and PD-maps, thus adding objective data to the MRI exam. The technology will be studied for its potential to add diagnostic value for various clinical applications including characterization of brain tumors.SyMRI IMAGE generates multiple contrast images from a single 3 to 6 minutes scan, thus allowing a significant reduction in scan time compared to serial